Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Aleniglipron showed 11.3% placebo-adjusted weight loss at 120 mg in the Phase 2b ACCESS study (36 weeks), with a higher exploratory dose reaching 15.3%
The decision is specifically about 503A compounded prescriptions for patients
To put this into perspective: Someone weighing 120 kg could potentially lose around 29 kg , although individual results vary considerably
Finding ways to better study GLP-1 users going it alone is a place to start
US$ 24.35
US$ 20.82
US$ 29.81
US$ 25.79
US$ 23.58
US$ 28.07
